Bayer Changes Pharma Leadership On Eve Of U.S. Stock Listing
This article was originally published in The Tan Sheet
Executive Summary
Bayer global pharmaceutical business head Wolfgang Plischke's range of experience within Bayer's different healthcare divisions is keeping with the company's plan to combine the divisions into a stand-alone unit